If a patient on a 70/30 insulin regimen (70 % NPH, 30 % regular) has a dangerously high capillary blood glucose, should I give an emergency dose of regular insulin since rapid‑acting insulin is unavailable?

Emergency Management of Dangerously High Blood Glucose in Patients on 70/30 Insulin

Yes, give emergency regular insulin as supplemental correction doses when a patient on 70/30 insulin develops dangerously high blood glucose, since rapid-acting insulin is unavailable at your facility. Regular insulin is an acceptable alternative to rapid-acting analogs for correction of hyperglycemia in hospitalized patients 1, 2.

Immediate Action Algorithm

When encountering dangerously high capillary blood glucose (typically >300-400 mg/dL) in a patient on 70/30 insulin:

1. Administer subcutaneous regular insulin as correction dose based on the patient's insulin sensitivity

   • Regular insulin onset: 30 minutes, peak: 2-4 hours, duration: 6-8 hours 3
   • Dose according to a correction scale (NOT sliding scale alone - see below)
   • Check blood glucose every 2-4 hours initially

2. Do NOT stop or adjust the scheduled 70/30 insulin immediately - continue the basal-bolus regimen while adding correction doses

3. Assess for precipitating factors: infection, medication non-adherence, steroid use, inadequate insulin dosing, or diabetic ketoacidosis

Critical Distinction: Correction Insulin vs. Sliding Scale

The key difference matters for patient outcomes: Correction insulin is given in addition to scheduled basal insulin, while sliding scale insulin (SSI) is reactive-only dosing without basal coverage 2. Guidelines explicitly discourage SSI alone because it fails to provide adequate glycemic control 1.

• Correction insulin therapy: Regular insulin dosed based on pre-meal or every 4-6 hour blood glucose readings, combined with your patient's existing 70/30 regimen 2
• Sliding scale insulin (discouraged): Reactive approach without regard to scheduled insulin or individualization 1, 2

Regular Insulin as Rapid-Acting Alternative

Since your hospital lacks rapid-acting analogs (lispro, aspart, glulisine), regular insulin is the appropriate substitute:

• Efficacy: Regular insulin achieves similar blood glucose reduction compared to rapid-acting analogs in emergency settings (41.5 mg/dL/h vs 47 mg/dL/h, p=0.36) 4
• Safety profile: Comparable hypoglycemia rates to rapid-acting insulin 4
• Timing adjustment needed: Administer 30 minutes before meals (vs. immediately before with rapid-acting) due to slower onset 3

Reassessing the 70/30 Regimen

After stabilizing the acute hyperglycemia, evaluate whether the 70/30 insulin regimen remains appropriate:

When 70/30 insulin works well:

• Patients with regular meal intake
• Stable nutritional status
• Predictable daily routine
• Studies show 70/30 insulin can achieve adequate control when dosed appropriately 5, 6

When to transition away from 70/30:

• Erratic eating patterns or NPO status
• Critical illness requiring ICU-level care (switch to IV insulin infusion) 1
• Frequent hypoglycemia or severe hyperglycemic excursions
• Need for more flexible dosing

Preferred alternative regimen: Basal insulin (NPH if long-acting analogs unavailable) plus scheduled regular insulin before meals with correction doses 1, 2. This basal-bolus approach provides superior glycemic control in most hospitalized patients with adequate nutritional intake 1.

Common Pitfalls to Avoid

1. Never use correction insulin alone without basal coverage - this is the fundamental error of sliding scale-only regimens 1

2. Don't mix 70/30 insulin with other insulins - it's a premixed formulation 3

3. Avoid stacking insulin doses - regular insulin lasts 6-8 hours, so wait at least 4 hours between correction doses to prevent cumulative hypoglycemia 3

4. Don't forget to check for DKA - dangerously high glucose may indicate diabetic ketoacidosis requiring IV insulin infusion, not subcutaneous correction 1

5. Monitor potassium levels - insulin administration can cause hypokalemia (7.9% incidence with IV insulin) 7

Monitoring Protocol

• Check blood glucose every 2-4 hours initially after correction dose
• Once stable, transition to pre-meal and bedtime monitoring (4 times daily minimum) 1
• Document all hypoglycemic episodes (BG <70 mg/dL) and adjust regimen to prevent recurrence 1
• Track total daily insulin requirements to guide regimen adjustments

Bottom line: Regular insulin correction doses are safe and effective for managing acute hyperglycemia in patients on 70/30 insulin when rapid-acting analogs are unavailable, but the underlying scheduled insulin regimen likely needs optimization if dangerously high glucose levels are occurring 1, 2, 4.